Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML
Status:
RECRUITING
Trial end date:
2027-12-30
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy and safety of the combination of idarubicin and cytarabine induction followed by intermediate-dose cytarabine consolidation with venetoclax in the treatment of newly diagnosed adult acute myeloid leukemia (AML).
This study includes the induction and consolidation phases of AML treatment.
Phase:
NA
Details
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Collaborators:
Huai'an First People's Hospital Yancheng First People's Hospital